Diagnosis of thrombotic thrombocytopenic purpura based on modulation by patient plasma of normal platelet adhesion under flow condition

British Journal of Haematology

Volumn 120, Issue 4, 2003, Pages 597-604

  Shenkman, Boris ^a   Inbal, Aida ^a,b   Tamarin, Ilia ^a   Lubetsky, Aharon ^a   Savion, Naphtali ^b   Varon, David ^c  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Cone and plate(let) analyser; Platelet; TTP

Indexed keywords

IMMUNOGLOBULIN G;

ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DILUTION; FLOW RATE; HUMAN; LABORATORY TEST; PLASMAPHERESIS; PRIORITY JOURNAL; RELAPSE; REMISSION; SHEAR RATE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ACUTE DISEASE; HUMANS; INFANT, NEWBORN; PLASMAPHERESIS; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RECURRENCE; RISTOCETIN; SENSITIVITY AND SPECIFICITY;

EID: 0037325159     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04119.x     Document Type: Article

References (39)

1. Ajzenberg, N., Denis, C.V., Veyradier, A., Girma, J.-P., Meyer, D. & Baruch, D. (2002) Complete defect in vWF-cleaving protease activity associated with increased shear-induced platelet aggregation in thrombotic microangiopathy. Thrombosis and Haemostasis, 87, 808-811.
2. Amorosi, E.L. & Ultmann, J.E. (1966) Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine, 45, 139-159.
3. Cmes, D.B., Konkle, B.A. & Furlan, M. (2000) Thrombotic thrombocytopenic purpura: a paradigm shift? Thrombosis and Haemostasis, 84, 528-535.
4. Dent, J.A., Berkowitz, S.D., Ware, J., Kasper, C.K. & Ruggeri, Z.M. (1990) Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand disease. Proceedings of National Academy of Sciences of the United States of America. 87, 6306-6310.
5. Fessler, B.J. (1997) Thrombotic syndromes and autoimmune diseases. Rheumatic Diseases Clinics of North America, 23, 461-479.
6. Fujikawa, K., Suzuki, H., McMullen, B. & Chung, D. (2001) Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloprotease family. Blood, 98, 1662-1666.
7. Furlan, M., Robles, R. & Lammle, B. (1996) Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vitro proteolysis. Blood, 87, 4223-4234.
8. Furlan, M., Robles, R., Solenthaler, M., Wassmer, M., Sandoz, P. & Lammle, B. (1997) Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood, 89, 3097-3103.
9. Furlan, M., Robles, R., Solenthaler, M. & Lammle, B. (1998a) Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood, 91, 2839-2846.
10. Furlan, M., Robles, R., Galbusera, M., Remuzzi, G., Kyrle, P.A., Brenner, B., Krause, M., Scharrer, I., Aumann, V., Mittler, U., Solenthaler, M. & Lammle, B. (1998b) Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. New England Journal of Medicine, 339, 1578-1584.
11. Furlan, M., Robles, R., Morselli, B., Sandoz, P. & Lammle, B. (1999) Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura. Thrombosis and Haemostasis, 81, 8-13.
12. Gerritsen, H.E., Turecek, P.L., Schwarz, H.P., Lammle, B. & Furlan, M. (1999) Assay of von Wlllebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thrombosis and Haemostasis, 82, 1386-1389.
13. Gerritsen, H.E., Robles, R., Lammle, B. & Furlan, M. (2001) Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood, 98, 1654-1661.
14. Goto, S.H., Salomon, D.R., Ikeda, Y. & Ruggeri, Z.M. (1995) Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor in platelets. Journal of Biological Chemistry, 270, 23352-23361.
15. Kakishita, E. (2000) Pathophysiology and treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS). International Journal of Hematology, 71, 320-327.
16. Levy, G.G., Nichols, W.C., Lian, E.C., Foroud, T., McClintick, J.N., McGee, B.M., Yang, A.Y., Siemieniak, D.R., Stark, K.R., Gruppo, R., Sarode, R., Shurin, S.B., Chandrasekaran, V., Stabler, S.P., Sabio, H., Bouhassira, E.E., Upshaw, Jr, J.D., Ginsburg, D. & Tsai, H.M. (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature, 413, 488-494.
17. Loof, A.H., van Viet, H.H. & Kappers-Klunne, M.C. (2001) Low activity of van Willebrand factor-cleaving protease is not restricted to patients suffering from thrombotic thrombocytopenic purpura. British Journal of Haematology, 112, 1087-1088.
18. Mannucci, P.M., Lombardi, R., Lattuada, A., Ruggenenti, P., Vigano, G.L., Barbui, T. & Remuzzi, G. (1989) Enhanced proteolysis of plasma yon Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. Blood, 74, 978-983.
19. Mannucci, P.M., Canciani, M.T., Forza, I., Lussana, F., Lattuada, A. & Ross, E. (2001) Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood, 98, 2730-2735.
20. Moake, J. (1997) Studies of the pathophysiology of thrombotic thrombocytopenic purpura. Seminars of Hematology, 34, 83-89.
21. Moake, J.L., Rudy, C.K., Troll, J.H., Weinstein, M.J., Colannino, N.M., Azocar, J., Seder, R.H., Hong, S.L. & Deykin, D. (1982) Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. New England Journal of Medicine, 307, 1432-1435.
22. Moake, J.L., Turner, N.A., Stathopoulos, N.A., Nolasco, L.H. & Hellums, J.D. (1986) Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. Journal of Clinical Investigation, 78, 1456-1461.
23. Moore, J.C., Hayward, C.P.M., Warkentin, T.E. & Kelton, J.G. (2001) Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders. Blood, 98, 1842-1846.
24. Obert, B., Toul, H., Veyradier, A., Fressinand, E., Meyer, D. & Girma, J.-P. (1999) Rapid and sensitive estimation of the vWF-cleaving protease in plasma using monoclonal antibodies to vWF. Thrombosis and Haemostasis, 82, 1382-1385.
25. Porta, C., Caporali, R. & Montecucco, C. (1999) Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadows and suspects. Haematologica, 84, 260-269.
26. Raife, T.J. & Montgomery, R.R. (2000) Von Willebrand factor and thrombotic thrombocytopenic purpura. Current Opinion Hematology, 7, 278-283.
27. Rock, G.A. (2000) Management of thrombotic thrombocytopenic purpura. British Journal of Haematology, 109, 496-507.
28. Saphier, C.J. & Repke, J.T. (1998) Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a review of diagnosis and management. Seminars in Perinatology, 22, 118-133.
29. Shenkman, B., Linder, N., Savion, N., Tamarin, I., Dardik, R., Kennet, G., German, B. & Varon, D. (1999) Increased neonatal platelet deposition on subendothellum under flow conditions: the role of plasma von Willebrand factor. Pediatric Research, 45, 270-275.
30. Shenkman, B., Savion, N., Dardik, R., Tamarin, I. & Varon, D. (2000) Testing of platelet deposition on polystyrene surface under flow conditions by the cone and plate(let) analyzer: role of platelet activation, fibrinogen and von Willebrand factor. Thrombosis Research, 99, 353-361.
31. Shenkman, B., Schneiderman, J., Tamarin, I., Kotev-Emeth, S., Savion, N. & Varon, D. (2001) Testing the effect of GPIIb-IIIa antagonist in patients undergoing carotid stenting: correlation between standard aggregometry, flow cytometry and the cone and plate(let) analyzer (CPA) methods. Thrombosis Research, 102, 311-317.
32. Thompson, C.E., Damon, L.E., Ries, C.A. & Linker, C.A. (1992) Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood, 80, 1890-1895.
33. Tsai, H.-M. (1996) Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood, 87, 4235-4244.
34. Tsai, H.M. & Lian, E.C.Y. (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. New England Journal of Medicine, 339, 1585-1594.
35. Varon, D., Dardik, R., Shenkman, B., Kotev-Emeth, S., Farzame, N., Tamarin, I. & Savion, N. (1997) A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thrombosis Research, 85, 283-294.
36. Varon, D., Lashevski, I., Brenner, B., Beyar, R. Lanir, N., Tamarin, I. & Savion, N. (1998) Cone and plate(let) analyzer: monitoring glycoprotein IIb/IIIa antagonists and von Willebrand disease replacement therapy by testing platelet deposition under flow conditions. American Heart Journal, 135, s187-s193.
37. Veyradier, A., Obert, B., Houllier, A., Meyer, D. & Girma, J.-P. (2001) Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood, 98, 1765-1772.
38. Weinstein, M., Blanchard, R., Moake, J., Vosburg, E. & Moise, K. (1989) Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura. British Journal of Haematology, 72, 68-72.
39. Wright, J.F., Wang, H., Hornstein, A., Hogarth, M., Mody, M., Garvey, M.B., Blanchette, V., Rock, G. & Freedman, J. (1999) Characterization of platelet glycoproteins and platelet/endothelial cell antibodies in patients with thrombotic thrombocytopenic purpura. British Journal of Haematology, 107, 546-555.